Bosh sahifaGNMSF • OTCMKTS
add
Genmab
Yopilish kursi
193,13 $
Kunlik diapazon
196,20 $ - 197,45 $
Yillik diapazon
170,00 $ - 305,09 $
Bozor kapitalizatsiyasi
13,11 mlrd USD
Oʻrtacha hajm
3,28 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
CPH
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (DKK) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 715,00 mln | 18,57% |
Joriy xarajat | 485,00 mln | 5,43% |
Sof foyda | 195,00 mln | 1,56% |
Sof foyda marjasi | 27,27 | -14,35% |
Har bir ulushga tushum | 20,18 | 0,01% |
EBITDA | 200,00 mln | 58,73% |
Amaldagi soliq stavkasi | 20,08% | — |
Balans
Jami aktivlari
Jami passivlari
| (DKK) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 3,23 mlrd | -89,10% |
Jami aktivlari | 6,59 mlrd | -82,04% |
Jami passivlari | 1,29 mlrd | -69,16% |
Umumiy kapital | 5,30 mlrd | — |
Tarqatilgan aksiyalar | 63,34 mln | — |
Narxi/balansdagi bahosi | 2,31 | — |
Aktivlardan daromad | 1,79% | — |
Kapitaldan daromad | 2,18% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (DKK) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 195,00 mln | 1,56% |
Operatsiyalardan naqd pul | 287,00 mln | 31,05% |
Sarmoyadan naqd pul | -43,00 mln | 79,52% |
Moliyadan naqd pul | -13,00 mln | 84,71% |
Naqd pulning sof oʻzgarishi | 239,00 mln | 410,39% |
Boʻsh pul | 1,59 mlrd | 167,79% |
Haqida
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, the Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, and Genmab K.K. in Tokyo, Japan. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
Tashkil etilgan
1999
Sayt
Xodimlar soni
2 638
